Pentagon Claims 1,775% Boost in AI Use, Adoption Lags
The Pentagon reports a dramatic rise in AI usage, but fewer than half of employees are actively using tools. Experts ...
Watch For Fake Icos
Stay vigilant for fake initial coin offerings by examining whitepapers, token metrics, and regulatory disclosures to prevent losses.
17,900 articles
Forget Oral Wegovy: This Could Be a Bigger Win for Investors
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Sick Overseas Original Medicare Gap Narrows with Add-On
Medicare largely offers no overseas coverage, leaving travelers with big medical bills. This report examines gaps, a ...
Who’s Right Arbor Realty? Insiders Buy as Bears Circle
Insiders are loading up Arbor Realty Trust while bears keep a large short position. The clash over who’s right Arbor ...
Medicare Program Already Denying Care in 6 States, Report Finds
A six-state AI pilot for Original Medicare is delaying and denying care for certain procedures, drawing bipartisan sc...
Brightlight Capital Cuts Hilton Stake: Market Impact
A recent SEC filing shows Brightlight Capital trimmed its Hilton stake by 79,500 shares, reducing the position's valu...
Bask Bank Review: Is It Right for Your Savings Strategy?
Bask Bank, the online arm of TEXAS CAPITAL Bank, blends a high-yield savings account with an American Airlines miles ...
This Week's Top Financial Stocks to Watch for 2026
Markets rally as rate expectations shift, lifting banks and fintechs. This week’s financial stocks week highlights th...
Market Punished This Consumer: Is It a Buy Now Opportunity?
A well-known consumer stock has faced a sharp sell-off as markets wobble. This guide breaks down why the market punis...
Rising Geopolitical Tensions Reason: Should You Sell TSM Stock?
Geopolitics are shaping the tech supply chain, and Taiwan Semiconductor sits at the center. This guide breaks down wh...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Nvidia Trades Times Forward: Is It a Real Value Play Today?
Nvidia has built an AI powerhouse, but its stock sits at a valuation that invites scrutiny. This guide breaks down wh...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status